IDH1/IDH2 mutations increase the risk of transformation from myelodysplastic syndrome (MDS) to high-risk AML and are associated with poor prognosis in AML, underscoring their role in disease progression [15,16]. The gene discussed is IDH2; the disease is myelodysplastic syndrome.